BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Gross Profit of -$77000.0 for Q1 2026, down 150.0% year-over-year from $154000.0 in Q1 2025, and down 134.38% quarter-over-quarter from $224000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Gross Profit history runs 5 years deep, the most recent figure standing at -$77000.0 for Q1 2026.
- In Q1 2026, Gross Profit fell 150.0% year-over-year to -$77000.0; the TTM figure through Mar 2026 stood at $247000.0 (up 209.29% YoY), while the FY2025 annual figure was $478000.0, up 288.62% from the prior year.
- Gross Profit for Q1 2026 stood at -$77000.0, down from $224000.0 in the prior quarter.
- The five-year high for Gross Profit was $1.0 million in Q2 2024, with the low at -$956000.0 in Q3 2024.
- The 5-year median for Gross Profit is $126000.0 (2022), against an average of $66466.7.
- Peak annual rise in Gross Profit reached 154.82% in 2024, while the deepest fall reached 459.06% in 2024.
- BioXcel Therapeutics' Gross Profit stood at $229000.0 in 2022, then tumbled by 247.6% to -$338000.0 in 2023, then sank by 37.87% to -$466000.0 in 2024, then soared by 148.07% to $224000.0 in 2025, then sank by 134.38% to -$77000.0 in 2026.
- Business Quant data shows BTAI's Gross Profit at -$77000.0 in Q1 2026, $224000.0 in Q4 2025, and $87000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | BioXcel Therapeutics | 24.40 Mn | 24.40 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 160,000.00 |
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 502,000.00 |
| Mar 31, 2024 | 502,000.00 |